Clinical Trials

How Did QEH Become UK's Fastest in Hip Fracture Research?
Research & Development How Did QEH Become UK's Fastest in Hip Fracture Research?

In a landscape where medical research often progresses at a cautious pace, the Queen Elizabeth Hospital (QEH) has emerged as a trailblazer, setting a remarkable benchmark in the United Kingdom by achieving the extraordinary feat of becoming the fastest site in the UK to recruit 100 participants for

Brello Health 2025: Top GLP-1 Telehealth Weight Loss Program
Tech & Innovation Brello Health 2025: Top GLP-1 Telehealth Weight Loss Program

In an era where obesity remains a pressing public health challenge, access to effective, safe, and personalized weight management solutions has never been more critical, and Brello Health stands at the forefront of this transformation with its innovative approach. This telehealth platform

Can Tumor Microbiota Predict Gastrointestinal Cancer Outcomes?
Research & Development Can Tumor Microbiota Predict Gastrointestinal Cancer Outcomes?

Imagine a future where a simple microbial profile from a tumor biopsy could predict a patient’s likelihood of surviving gastrointestinal (GI) cancer or responding to cutting-edge therapies. This isn’t science fiction—it’s a tangible possibility emerging from the intersection of microbiology and

Can Rare HIV Cures Lead to a Universal Immunotherapy?
Research & Development Can Rare HIV Cures Lead to a Universal Immunotherapy?

What if a tiny fraction of people held the key to eradicating one of humanity's most persistent viruses, offering hope to the over 38 million individuals living with HIV worldwide? This virus has defied a universal cure for decades, yet in a handful of remarkable cases, some have walked away

Can a Two-Hour Test Revolutionize Sepsis Diagnosis?
Tech & Innovation Can a Two-Hour Test Revolutionize Sepsis Diagnosis?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, and a deep understanding of technological innovation in the medical field. Today, we're diving into a groundbreaking advancement in sepsis detection that promises to

Baricitinib Safety Analysis in High-Risk Patient Groups
Research & Development Baricitinib Safety Analysis in High-Risk Patient Groups

In the rapidly evolving field of autoimmune disease treatment, Baricitinib, an oral Janus kinase (JAK) inhibitor, has carved out a significant role as a promising therapy for conditions such as rheumatoid arthritis and atopic dermatitis. For countless patients, particularly those in high-risk

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later